Showing results 1 to 20 of 54
next >
| Issue Date | Title | Author(s) |
| 2022-01 | Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD. | Becker, EJ; Faiz, A; van den Berge, M; Timens, W; Hiemstra, PS; Clark, K; Liu, G; Xiao, X; Alekseyev, YO; O'Connor, G; Lam, S; Spira, A; Lenburg, ME; Steiling, K |
| 2021-02-27 | Applying evidence-based symptomatic treatments from other clinical disciplines to palliative care. | Kochovska, S; Agar, MR; Phillips, JL; Tieman, J; Sheehan, C; Clark, K; Currow, DC |
| 2021-01-28 | A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer | Currow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR |
| 2021-01-01 | Defining the trials nurses’ role in operationalising a medicinal cannabis clinical trial | Razmovski-Naumovski, V; West, PA; Bellemore, F; Byfieldt, N; Bellamy, D; Chye, R; Clark, K; Martin, JH; Fazekas, B; Phillips, JL; Agar, MR |
| 2020-10-31 | Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide. | McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC |
| 2020-07-01 | Levetiracetam at the End of Life: A Case Report and Discussion | Mohamudally, A; Clark, K |
| 2020-07 | Opioids for Breakthrough Cancer Pain. | Currow, DC; Clark, K |
| 2020-05 | A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. | Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR |
| 2020-05 | Response to Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A (2020) MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer 28:23. | Clark, K; Currow, DC |
| 2020-03-01 | Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled Trial | Ferreira, DH; Louw, S; McCloud, P; Fazekas, B; McDonald, CF; Agar, MR; Clark, K; McCaffrey, N; Ekström, M; Currow, DC |
| 2020-01-03 | Pharmacovigilance in Hospice/Palliative Care: De-Prescribing Combination Controlled Release Oxycodone-Naloxone | Clark, K; Byrne, PG; Hunt, J; Brown, L; Rowett, D; Watts, G; Lovell, M; Currow, DC |
| 2019-01-01 | Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes Collaboration | Matsuoka, H; Allingham, S; Fazekas, B; Brown, L; Vandersman, Z; Clark, K; Agar, MR; Currow, DC |
| 2019-01-01 | Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial | Currow, DC; Ekström, M; Louw, S; Hill, J; Fazekas, B; Clark, K; Davidson, PM; McDonald, C; Sajkov, D; McCaffrey, N; Doogue, M; Abernethy, AP; Agar, M |
| 2018-11-01 | A pragmatic comparative study of palliative care clinician’s reports of the degree of shadowing visible on plain abdominal radiographs | Clark, K; Lam, L; Talley, NJ; Watts, G; Phillips, JL; Byfieldt, NJ; Currow, DC |
| 2018-09-01 | Clinician-reported changes in octreotide prescribing for malignant bowel obstruction as a result of an adequately powered phase III study: A transnational, online survey | Campbell, R; McCaffrey, N; Brown, L; Agar, MR; Clark, K; Currow, DC |
| 2017-05-01 | Identifying factors that predict worse constipation symptoms in palliative care patients: A secondary analysis | Clark, K; Lam, LT; Talley, NJ; Phillips, JL; Currow, DC |
| 2016-12-01 | Physical Symptoms at the Time of Dying Was Diagnosed: A Consecutive Cohort Study to Describe the Prevalence and Intensity of Problems Experienced by Imminently Dying Palliative Care Patients by Diagnosis and Place of Care | Clark, K; Connolly, A; Clapham, S; Quinsey, K; Eagar, K; Currow, DC |
| 2016-11-01 | Study protocol: A phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness | Watts, GJ; Clark, K; Agar, M; Davidson, PM; McDonald, C; Lam, LT; Sajkov, D; McCaffrey, N; Doogue, M; Abernethy, AP; Currow, DC |
| 2016-10-03 | Using opioids in general practice for chronic non-cancer pain: an overview of current evidence | Currow, DC; Phillips, J; Clark, K |
| 2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
